AltPep
Dr. Roh serves as the Director of Minimally Invasive Spine Surgery at the Swedish Neuroscience Institute and Chairman of Swedish Hospital’s Integrated Spine Program. He has more than 15 years of experience as an inventor, angel investor, and serial entrepreneur and holds multiple patents.
This person is not in the org chart
This person is not in any offices
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).